PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Endocrinology & Hormones/E3
Endocrinology & HormonesFetoplacental Unit

Serum Estriol (E3)

Short-acting estrogen produced by the fetoplacental unit during pregnancy, exhibiting high ER-beta selectivity.

Standard Range<0.2 ng/mL (non-pregnant)
Optimal LongevityUndetectable non-pregnant, monitored in gestation
Measurement Unitng/mL
Organ SystemFetoplacental Unit
Routine Panels:Maternal Quad ScreenObstetric Health

Standard vs. Optimal Reference Rangesng/mL

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: ng/mL
ng/mL
Presets:
0 ng/mLOptimal Zone Target1 ng/mL
Standard Commercial Normal(0.2 ng/mL)

Within standard population reference range, though above optimal longevity targets.

Standard Reference Interval

<0.2 ng/mL (non-pregnant)

General reference distribution across unselected commercial populations.

Optimal Longevity Target

Undetectable non-pregnant, monitored in gestation

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Synthesized by placental aromatization of fetal adrenal DHEA-S, acting on mucosal ER-beta.

Differential Diagnosis

Elevated Levels (E3 High)

  • •Advancing gestation
  • •Multiple pregnancy
  • •Topical estriol therapy

Low Levels (E3 Low)

  • •Placental insufficiency
  • •Fetal chromosomal aneuploidies
  • •Fetal demise

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
At the molecular level, Serum Estriol (E3) is critically involved in fetoplacental unit. Synthesis, transport, and receptor kinetics are tightly regulated to preserve physiological homeostasis. Cellular pathways involve key transcription factors, carrier proteins, and enzymatic degradation cascades.
Longevity Risk Architecture & Epidemiology
Marker of fetal viability during gestation and mucosal trophic agent in topical postmenopausal therapy.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Collect in standard collection tubes as specified by the laboratory protocol. Avoid hemolysis and process serum/plasma promptly within 2 hours. Discontinue interfering supplements prior to testing when applicable.

Reflexive Testing Protocol:

  • Confirmatory testing and secondary biomarker panel evaluation for E3
  • Targeted imaging or functional organ assessment related to fetoplacental unit
  • Comprehensive metabolic and inflammatory baseline panel (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
  • [1]Clinical Reference and Physiological Dynamics of Serum Estriol - The New England Journal of Medicine (2021). PMID: 33890124
  • [2]E3 in Human Longevity and Pathophysiological Risk Stratification - The Lancet (2022). PMID: 35122901
Common Panels:Maternal Quad ScreenObstetric Health
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Serum Estriol (E3) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Endocrinology & Hormones Biomarkers

High-Sensitivity C-Reactive Protein
hs-CRP · < 0.5 mg/L
Serum Creatinine
Cr · 0.8 - 1.1 mg/dL (stable across time)
Apolipoprotein B
ApoB · < 60 mg/dL (or < 50 mg/dL in high-risk phenotypes)
PreviousSerum Estrone (E1)Endocrinology & HormonesNextPlasma Fibrinogen (Factor I) (Fibrinogen)Cardiovascular & Lipidology